These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 37296355)
1. Cardiovascular disease (CVD) outcomes and associated risk factors in a medicare population without prior CVD history: an analysis using statistical and machine learning algorithms. Lip GYH; Genaidy A; Estes C Intern Emerg Med; 2023 Aug; 18(5):1373-1383. PubMed ID: 37296355 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Disease Burden and Outcomes Among American Indian and Alaska Native Medicare Beneficiaries. Eberly LA; Shultz K; Merino M; Brueckner MY; Benally E; Tennison A; Biggs S; Hardie L; Tian Y; Nathan AS; Khatana SAM; Shea JA; Lewis E; Bukhman G; Shin S; Groeneveld PW JAMA Netw Open; 2023 Sep; 6(9):e2334923. PubMed ID: 37738051 [TBL] [Abstract][Full Text] [Related]
3. Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach. Lip GYH; Genaidy A; Tran G; Marroquin P; Estes C Eur J Intern Med; 2021 Sep; 91():53-58. PubMed ID: 34023150 [TBL] [Abstract][Full Text] [Related]
4. Incident and recurrent myocardial infarction (MI) in relation to comorbidities: Prediction of outcomes using machine-learning algorithms. Lip GYH; Genaidy A; Tran G; Marroquin P; Estes C; Shnaiden T; Bayewitz A Eur J Clin Invest; 2022 Aug; 52(8):e13777. PubMed ID: 35349732 [TBL] [Abstract][Full Text] [Related]
5. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460 [TBL] [Abstract][Full Text] [Related]
6. HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database. Alonso A; Barnes AE; Guest JL; Shah A; Shao IY; Marconi V J Am Heart Assoc; 2019 Jul; 8(14):e012241. PubMed ID: 31266386 [TBL] [Abstract][Full Text] [Related]
7. Incidence and Complications of Atrial Fibrillation in a Low Socioeconomic and High Disability United States (US) Population: A Combined Statistical and Machine Learning Approach. Lip GYH; Genaidy A; Tran G; Marroquin P; Estes C Int J Clin Pract; 2022; 2022():8649050. PubMed ID: 36110264 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study. Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults: A Population-Based Cohort Study. Yang Q; Chang A; Ritchey MD; Loustalot F J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647688 [TBL] [Abstract][Full Text] [Related]
10. Incidence of ischemic stroke or transient ischemic attack in patients with multiple risk factors with or without atrial fibrillation: a retrospective cohort study. Yuan Z; Makadia R; Ryan P; Yannicelli D; Nessel C; Sarich T Curr Med Res Opin; 2015; 31(7):1257-66. PubMed ID: 25877807 [TBL] [Abstract][Full Text] [Related]
11. Revisiting the dynamic risk profile of cardiovascular/non-cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular/non-cardiovascular outcomes: A machine-learning approach. Lip GYH; Tran G; Genaidy A; Marroquin P; Estes C J Arrhythm; 2021 Aug; 37(4):931-941. PubMed ID: 34386119 [TBL] [Abstract][Full Text] [Related]
12. Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups. Hong C; Pencina MJ; Wojdyla DM; Hall JL; Judd SE; Cary M; Engelhard MM; Berchuck S; Xian Y; D'Agostino R; Howard G; Kissela B; Henao R JAMA; 2023 Jan; 329(4):306-317. PubMed ID: 36692561 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239 [TBL] [Abstract][Full Text] [Related]
14. Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years. Seki H; Kaneko H; Morita H; Itoh H; Morita K; Matsuoka S; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Yano Y; Nakamura S; Node K; Yasunaga H; Komuro I Am J Cardiol; 2021 Aug; 152():150-157. PubMed ID: 34140140 [TBL] [Abstract][Full Text] [Related]
15. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. Hippisley-Cox J; Coupland C; Brindle P BMJ; 2013 May; 346():f2573. PubMed ID: 23641033 [TBL] [Abstract][Full Text] [Related]
16. Machine learning model for cardiovascular disease prediction in patients with chronic kidney disease. Zhu H; Qiao S; Zhao D; Wang K; Wang B; Niu Y; Shang S; Dong Z; Zhang W; Zheng Y; Chen X Front Endocrinol (Lausanne); 2024; 15():1390729. PubMed ID: 38863928 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation. Aguilar E; García-Díaz AM; Sánchez Muñoz-Torrero JF; Alvarez LR; Piedecausa M; Arnedo G; Monreal M; Thromb Res; 2012 Sep; 130(3):390-5. PubMed ID: 22658293 [TBL] [Abstract][Full Text] [Related]
18. Atrial Fibrillation and Cardiovascular Outcomes in the Elderly. O'Neal WT; Salahuddin T; Broughton ST; Soliman EZ Pacing Clin Electrophysiol; 2016 Sep; 39(9):907-13. PubMed ID: 27333877 [TBL] [Abstract][Full Text] [Related]
19. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial. Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395 [TBL] [Abstract][Full Text] [Related]